ChemicalBook > Product Catalog >API >Blood System Drugs >Antianemia Drugs >Deferasirox

Deferasirox

Deferasirox Structure
CAS No.
201530-41-8
Chemical Name:
Deferasirox
Synonyms
20kg;Exjade;4-[3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid;ICL-670;Delarox;CGP-72670;eferasirox;deferasirox;Deferisirox;Deferasirox D8
CBNumber:
CB7855359
Molecular Formula:
C21H15N3O4
Molecular Weight:
373.36
MOL File:
201530-41-8.mol
Modify Date:
2024/8/13 17:19:14

Deferasirox Properties

Melting point 260-2620C
Boiling point 672.1±65.0 °C(Predicted)
Density 1.40±0.1 g/cm3(Predicted)
storage temp. Keep in dark place,Inert atmosphere,2-8°C
solubility Soluble in DMSO (10 mg/ml)
form solid
pka pKa1 4.57, pKa2 8.71, pKa3 10.56 (Nick); Also reported in H2O/DMSO (CDMSO = 0.20) as pKa1 4.61, pKa2 10.12, pKa3 12.08 (Steinhauser)
color Off-white to white
Stability Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS09
Signal word  Warning
Hazard statements  H410
Precautionary statements  P273-P391-P501
HS Code  2933997500
NFPA 704
0
3 0

Deferasirox Chemical Properties,Uses,Production

Description

Linagliptin was originally discovered at Boehringer Ingelheim as an orally active dipeptidyl peptidase-IV (DPP-4) inhibitor. Eli Lilly and Boehringer Ingelheim co-developed and launched linagliptin for type II diabetes as an adjunct to diet and exercise for the improvement of adult glycemic control. Linagliptin has a superior DPP-4 IC50 value of 1 nM, compared with 19 nM for sitagliptin, 24 nM for alogliptin, 50 nM for saxagliptin and 62 nM for vildagliptin. In addition, linagliptin exhibited prolonged pharmacodynamic activity with long-lasting DPP-4 inhibition in several preclinical species. Linagliptin showed good efficacy in phase II clinical trials with doses as low as 5 mg and no signs of hypoglycemia with doses as high as 600 mg. The prolonged pharmacological effect of DPP-4 activity and the good safety/tolerability profile provided the basis for linagliptin’s approval.

Chemical Properties

White to Off-White Solid

Uses

Biological Activity Chemical Information Tech Support & FAQs Biological Activity Deferasirox(Exjade) is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions

Definition

ChEBI: A member of the class of triazoles, deferasirox is 1,2,4-triazole substituted by a 4-carboxyphenyl group at position 1 and by 2-hydroxyphenyl groups at positions 3 and 5. An orally active iron chelator, it is used to manage chronic iron overload in patient receiving long-term blood transfusions.

Global( 411)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
SIMSON PHARMA LIMITED +91-8291074273 Shanghai, India 228 58 Inquiry
Cadila Pharmaceuticals Ltd +91-7069076657 +91-7069076657 Ahmedabad, India 54 58 Inquiry
SURYA LIFE SCIENCES LIMITED +91-2646226290 +91-9428511112 Gujarat, India 62 58 Inquiry
Siddhivinayakchemicals +91-912225190111 +91-9819773074 Mumbai, India 42 58 Inquiry
Flax Laboratories +91-9867665132 +91-9867665132 Maharashtra, India 44 58 Inquiry
AARTIA KEM SCIENCE +91-8291072530 +91-8291072530 Maharashtra, India 70 58 Inquiry
Gonane Pharma +91-9819380043 +91-9819380043 NaviMumbai, India 192 58 Inquiry
Vedzon Healthcare Pvt Ltd +91-9322176000 +91-9322176000 Maharashtra, India 51 58 Inquiry
Apotex Pharmachem India Pvt Ltd +91-8022891034 +91-8022891000 Karnataka, India 109 58 Inquiry
Piramal Pharma Solutions +919892735994 Maharashtra, India 48 58 Inquiry

Deferasirox Spectrum

Deferasirox(CGP-72670) Deferasirox(Exjade) 4-[3,5-bis(2-hydroxyphenyl) Deferasirox, >=99% Deferasirox D8 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid deferasirox Deferasirox for research 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic Acid CGP-72670 ICL-670 Benzoic acid, 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]- Deferasirox D8Q: What is Deferasirox D8 Q: What is the CAS Number of Deferasirox D8 Q: What is the storage condition of Deferasirox D8 Q: What are the applications of Deferasirox D8 Deferasirox for system suitability (Y0002197)Q: What is Deferasirox for system suitability (Y0002197) Q: What is the CAS Number of Deferasirox for system suitability (Y0002197) DeferasiroxQ: What is Deferasirox Q: What is the CAS Number of Deferasirox Q: What is the storage condition of Deferasirox Q: What are the applications of Deferasirox 4-[3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoicaChemicalbookcid Deferisirox Decitabine USP RC C [14C]Deferasirox [14C]4-[3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid 4-[bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid Deferasirox USP/EP/BP Deferasirox (ICL 670) 4-[3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid 20kg Exjade Deferasirox Deferasirox(API) eferasirox Delarox Deferasirox (200 mg) Deferasirox IP/EP/INH 201530-41-8 530-41-8 140891-02-6 C21H15N3O4 Pharmaceutical intermediate Aromatics Chelating Agents & Ligands Heterocycles Intermediates & Fine Chemicals Pharmaceuticals Exjade, ICL-670, ICL-670A, CGP-72670 Chelating agent (iron) Aromatics Compounds 1